Physicochemical Properties
| Molecular Formula | C4H5NO3 |
| Molecular Weight | 115.09 |
| Exact Mass | 115.027 |
| CAS # | 557-24-4 |
| PubChem CID | 5280451 |
| Appearance | White to off-white solid powder |
| Density | 1.376g/cm3 |
| Boiling Point | 408.6ºC at 760mmHg |
| Melting Point | 158-161 °C(lit.) |
| Flash Point | 200.9ºC |
| Index of Refraction | 1.528 |
| LogP | -1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 8 |
| Complexity | 138 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C(=C\C(=O)O)\C(=O)N |
| InChi Key | FSQQTNAZHBEJLS-UPHRSURJSA-N |
| InChi Code | InChI=1S/C4H5NO3/c5-3(6)1-2-4(7)8/h1-2H,(H2,5,6)(H,7,8)/b2-1- |
| Chemical Name | (Z)-4-amino-4-oxobut-2-enoic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Additional Infomation |
Maleamic acid is a dicarboxylic acid monoamide of maleamic acid. It has a role as an Escherichia coli metabolite and a bacterial xenobiotic metabolite. It is a dicarboxylic acid monoamide and an alpha,beta-unsaturated monocarboxylic acid. It is functionally related to a maleic acid. It is a conjugate acid of a maleamate. Maleamic acid has been reported in Pogostemon cablin and Trypanosoma brucei with data available. |
Solubility Data
| Solubility (In Vitro) | DMSO :~100 mg/mL (~868.89 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (18.07 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (18.07 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (18.07 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 8.6889 mL | 43.4443 mL | 86.8885 mL | |
| 5 mM | 1.7378 mL | 8.6889 mL | 17.3777 mL | |
| 10 mM | 0.8689 mL | 4.3444 mL | 8.6889 mL |